BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17853009)

  • 1. Short-term effect of simvastatin treatment on inflammatory parameters in peritoneal dialysis patients.
    Sezer MT; Katirci S; Demir M; Erturk J; Adana S; Kaya S
    Scand J Urol Nephrol; 2007; 41(5):436-41. PubMed ID: 17853009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.
    Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y
    Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients.
    Panichi V; Paoletti S; Mantuano E; Manca-Rizza G; Filippi C; Santi S; Taccola D; Donadio C; Tramonti G; Innocenti M; Casto G; Consani C; Sbragia G; Franzoni F; Galetta F; Panicucci E; Barsotti G
    Nephrol Dial Transplant; 2006 Feb; 21(2):337-44. PubMed ID: 16249194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of human recombinant erythropoietin on inflammatory status in peritoneal dialysis patients.
    Aguilera A; Bajo MA; Díez JJ; Ruiz-Caravaca ML; Vicenta Cuesta M; Alvarez V; Codoceo R; Selgas R
    Adv Perit Dial; 2002; 18():200-5. PubMed ID: 12402619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients.
    Chang JW; Yang WS; Min WK; Lee SK; Park JS; Kim SB
    Am J Kidney Dis; 2002 Jun; 39(6):1213-7. PubMed ID: 12046033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of simvastatin on pro-inflammatory cytokines in patients with hypercholesterolemia.
    Zubelewicz-Szkodzińska B; Szkodziński J; Danikiewicz A; Romanowski W; Błazelonis A; Muc-Wierzgon M; Pietka-Rzycka A; Muryn Z
    Kardiol Pol; 2003 Dec; 59(12):465-74. PubMed ID: 14724693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis.
    Tikiz C; Utuk O; Pirildar T; Bayturan O; Bayindir P; Taneli F; Tikiz H; Tuzun C
    J Rheumatol; 2005 Nov; 32(11):2095-101. PubMed ID: 16265685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin.
    Goldstein SL; Leung JC; Silverstein DM
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):979-86. PubMed ID: 17699316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of simvastatin on serum cytokine levels and bone metabolism in postmenopausal subjects: negative correlation between TNF-alpha and anabolic bone parameters.
    Tikiz C; Unlü Z; Tikiz H; Ay K; Angin A; Onur E; Var A; Tüzün C
    J Bone Miner Metab; 2004; 22(4):365-71. PubMed ID: 15221496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperleptinaemia and chronic inflammation after peritonitis predicts poor nutritional status and mortality in patients on peritoneal dialysis.
    Lam MF; Leung JC; Lo WK; Tam S; Chong MC; Lui SL; Tse KC; Chan TM; Lai KN
    Nephrol Dial Transplant; 2007 May; 22(5):1445-50. PubMed ID: 17277343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of treatment with omega-3 fatty acids on C-reactive protein and tumor necrosis factor-alfa in hemodialysis patients.
    Tayyebi-Khosroshahi H; Houshyar J; Dehgan-Hesari R; Alikhah H; Vatankhah AM; Safaeian AR; Zonouz NR
    Saudi J Kidney Dis Transpl; 2012 May; 23(3):500-6. PubMed ID: 22569435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data.
    Basyigit I; Yildiz F; Ozkara SK; Yildirim E; Boyaci H; Ilgazli A
    Ann Pharmacother; 2004 Sep; 38(9):1400-5. PubMed ID: 15252191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis.
    Maksić D; Colić M; Stanković-Popović V; Radojević M; Bokonjić D
    Med Pregl; 2007; 60 Suppl 2():53-7. PubMed ID: 18928158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin reduces endotoxin-induced nuclear factor kappaB activation and mortality in guinea pigs despite lowering circulating low-density lipoprotein cholesterol.
    Fraunberger P; Gröne E; Gröne HJ; Walli AK
    Shock; 2009 Aug; 32(2):159-63. PubMed ID: 19008785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin decreases myocardial tumor necrosis factor alpha content in heart transplant recipients.
    Wallace CK; Stetson SJ; Küçüker SA; Becker KA; Farmer JA; McRee SC; Koerner MM; Noon GP; Torre-Amione G
    J Heart Lung Transplant; 2005 Jan; 24(1):46-51. PubMed ID: 15653378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease.
    Dummer CD; Thome' FS; Zingano B; Lindoso A; Veronese FV
    J Nephrol; 2008; 21(6):900-8. PubMed ID: 19034875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-Arginine enhances the triglyceride-lowering effect of simvastatin in patients with elevated plasma triglycerides.
    Schulze F; Glos S; Petruschka D; Altenburg C; Maas R; Benndorf R; Schwedhelm E; Beil U; Böger RH
    Nutr Res; 2009 May; 29(5):291-7. PubMed ID: 19555809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
    Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
    Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.